[Alternatives to digitalis therapy? Pharmacological basis].
D000200:Action Potentials / Q000187:drug effects; D000251:Adenosine Triphosphatases / Q000037:antagonists & inhibitors; D002118:Calcium / Q000378:metabolism / Q000627:therapeutic use; D002395:Catecholamines / Q000627:therapeutic use; D004071:Digitalis Glycosides / Q000494:pharmacology* / Q000627:therapeutic use; D005934:Glucagon / Q000627:therapeutic use; D006329:Heart Conduction System / Q000187:drug effects*; D006439:Hemodynamics / Q000187:drug effects*; D006801:Humans; D007832:Lasalocid / Q000627:therapeutic use; D011188:Potassium / Q000378:metabolism; D012964:Sodium / Q000378:metabolism; D014700:Verapamil / Q000627:therapeutic use; D014970:Xanthines / Q000627:therapeutic use
D002395:Catecholamines; D004071:Digitalis Glycosides; D014970:Xanthines; D005934:Glucagon; D012964:Sodium; D014700:Verapamil; D000251:Adenosine Triphosphatases; D011188:Potassium; D002118:Calcium; D007832:Lasalocid
Alternativen zur Digitalis-Therapie? Pharmakologische Grundlagen.